The in vivo tyrosine phosphorylation level of yeast immunophilin Fpr3 is influenced by the LMW-PTP Ltp1. by Magherini, Francesca et al.
www.elsevier.com/locate/ybbrc
Biochemical and Biophysical Research Communications 321 (2004) 424–431
BBRCThe in vivo tyrosine phosphorylation level of yeast immunophilin
Fpr3 is influenced by the LMW-PTP Ltp1
Francesca Magherini, Tania Gamberi, Paolo Paoli, Matilde Marchetta,
Massimiliano Biagini, Giovanni Raugei, Guido Camici,
Giampietro Ramponi, Alessandra Modesti *
Dipartimento di Scienze Biochimiche, Universita` degli Studi di Firenze, Florence, Italy
Received 18 June 2004Abstract
Tyr-phosphorylation in Saccharomyces cerevisiae is essential in controlling the activity of MAP kinase regulating mating, pseud-
ohyphal growth, and cell wall biosynthesis. Yeast serves as a model system for studying the biological function of many protein
kinases and PTPs. Two LMW-PTP from yeast have been cloned, namely, Ltp1 from S. cerevisiae and Stp1 from Schizosaccharo-
myces pombe. The sequences of both enzymes are relatively similar to those of the mammalian LMW-PTP. Recently we showed that
the yeast immunophilin Fpr3 interacts with Stp1 and its dephosphorylated state induces a growth defective phenotype. Here we
show the phosphatase activity of Ltp1 on Fpr3 and we demonstrated that Tyr 184 is the residue phosphorylated on in vivo
Fpr3. We also described the marked activation of Ltp1 by adenine in S. cerevisiae proteome and determined in vivo the influence
of tyrosine phosphorylation on Fpr3 localization.
 2004 Elsevier Inc. All rights reserved.
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diverse enzymes that have fundamental roles in cellular
processes, including effects on metabolism, cell prolifera-
tion, and differentiation [1]. Although in budding yeast
conventional tyrosine kinases are not present, Zhu et al.
[2] using a chip technology identified 27 kinases able
to phosphorylate poly-Glu-Tyr, a typical artificial
substrate of bona fide tyrosine kinases. Moreover, Tyr-
phosphorylation has been shown in Saccharomyces cere-
visiae to be essential in controlling the activity of MAP
(mitogen-activated-protein) kinases which, in turns regu-
late mating, osmosensing pseudohyphal and invasive
growth, spore wall assembly, and cell wall biosynthesis
[3]. The low-molecular weight protein tyrosine phospha-0006-291X/$ - see front matter  2004 Elsevier Inc. All rights reserved.
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E-mail address: modesti@scibio.unifi.it (A. Modesti).tases (LMW-PTP) are single-domain cytosolic enzymes
with molecular masses of approximately 18kDa. The ac-
tive site sequence motif of these enzymes has a conserved
(V/I)CXGNXCRS sequence. Members of this family
have been identified in a wide variety of organisms, in-
cluding bacteria, yeast, rat, bovine, and human [4–8],
suggesting that these enzymes have important cellular
functions. Yeast serves as a simple, but often useful, mod-
el system for studying the biological function of many
protein kinases and PTPs. Two LMW-PTP from yeast
have been cloned, namely, Ltp1 from S. cerevisiae [9]
and Stp1 from Schizosaccharomyces pombe [10]. The se-
quences of both enzymes are relatively similar to those
of the mammalian LMW-PTP, with identity of 42%
and 39% for the Stp1 and Ltp1, respectively. The physio-
logical role of the yeast enzymes is still unknown but
the mammalian LMW-PTP shows a broad range of
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caveolin [12], and the p190Rho GAP [13]. The activation
of mammalian LMW-PTP by purines or purine deriva-
tives, nucleosides, and nucleotides has been described
[14–16], together with the activity modulation of human
LMW-PTP by adenine and hypoxanthine [17]. The
mechanism of the activation of the LMW-PTP by purines
is not completely understood. In a recent paper studying
the structural basis for the activation of the Ltp1, Wang
et al. [18] suggested that adenine molecule activates the
enzyme by binding in the active site during the dephos-
phorylation step, showing the existence of a specific site
on the enzyme that is capable to bind the purine effectors.
In order to identify a possible role of the LMW-PTP in
yeast we demonstrated that the expression of the Stp1
LMW-PTP, or of its dominant negative mutant, in S. ce-
revisiae, affects the phosphoproteome of this organism
[19]. Moreover, in specific stress conditions, yeast strains
that express Stp1 show a phenotype correlated with low
cAMP level, suggesting an involvement of the protein
phosphorylation in the regulation of cAMP pathway (un-
published data). All these data indicate that tyrosine
phosphorylation in budding yeast is a more relevant pro-
cess than previously suspected.
In a recent paper we showed that the yeast immuno-
philin Fpr3 interacts with Stp1 and exhibits a negligible
level of tyrosine phosphorylation in Stp1 expressing
yeast cells if treated with a CK2 specific inhibitor [20].
A drastic reduction in Fpr3 tyrosine phosphorylation,
promoted by the concerted action of CK2 inhibition and
Stp1 expression, is accompanied by defective growth.
Fpr3 is a peptidylprolyl-cis,trans-isomerase (PPIase) act-
ing in conjunction with protein chaperones, accelerating
the rate of conformational interconversions around pro-
line residues in polypeptides [21]. The functions of PPI-
ase are still poorly understood, even if many of them
assist in the folding (or unfolding) of individual pro-
teins. Folding of many cellular proteins is facilitated
by molecular chaperones. Analysis of both prokaryotic
and lower eukaryotic model systems has revealed the
presence of ribosome-associated molecular chaperones,
thought to be the first line of defense against protein ag-
gregation as translating polypeptides emerge from the
ribosome [22]. In Drosophila melanogaster a mutation
in a cyclophilin causes misfolded forms of rhodopsin
[23]. PPIase are also required for the assembly of pro-
tein–protein complexes. Even if fpr3 null mutations
had no discernible phenotype [24], cells might be more
sensitive to stress conditions accumulating higher level
of misfolded proteins and aggregated unassembled pro-
teins than wild-type cells, which might act as a signal to
induce stress response. Localization of Fpr3 in the
nucleolus suggests possible roles of this PPIase in the
folding of ribosomal proteins, in the assembly of pre-ri-
bosomes or in the export of ribosomes to the cytoplasm
[25]. Furthermore, like other nucleolar proteins, it isphosphorylated in vivo. This modification may have a
consequence for the activity or localization of Fpr3.
The LMW-PTP from the yeast S. cerevisiae, Ltp1,
shows substrate specificity toward artificial substrates
that is generally similar to that exhibited by the homol-
ogous mammalian enzymes [9]. However, it is even more
activated by adenine, bringing its activity to a level com-
parable with those of its vertebrate counterparts [18].
Recently, two residues (W135 and Y136) were replaced
by site-directed mutagenesis to assess the role of some
residues, in the active site, in substrate recognition. Paoli
et al. described the kinetic properties of these mutants
and demonstrate that the molecular site, which deter-
mines adenine dependent activation, is also involved in
substrate recognition (unpublished data). All these find-
ings suggest that the substrate recognition by the en-
zyme is determined not only by the interaction of
phosphate moiety with the enzyme P-loop, but also by
favorable binding to some aromatic ring. In this paper
we studied the phosphatase activity of Ltp1 on Fpr3,
over-expressing the Ltp1 protein or its dominant nega-
tive mutant in S. cerevisiae. Moreover, we tested Fpr3
tyrosine phosphorylation level in a yeast mutant strain
not expressing Ltp1. Site-directed mutagenesis demon-
strated that Tyr 184 is the residue phosphorylated on
in vivo Fpr3. We described also the marked activation
of Ltp1 by adenine, resulting in changes in protein tyro-
sine phosphorylation in S. cerevisiae proteome in vivo.
Finally, we determined in vivo the influence of tyrosine
phosphorylation on Fpr3 localization.Materials and methods
Strains, growth media, and plasmid. The yeast strains used in this
study are described in Table 1. The parent strain is W303-1A MATa
leu2-3,112 ura3-1 trp1-92 his3-11,15 ade2-1 can1-100 GAL SUC mal.
Plasmid pAAH5 containing Ltp1 was constructed by a PCR experi-
ment on total yeast DNA from W303 wild-type strain using the
primers (5 0-GGCCAAGCTTATGACAATTGAAAAACC-3 0, 5 0-GG
CCAAGCTTCCGCACCATCATTAC-3 0), which contain a HindIII
site. The PCR fragment obtained was digested withHindIII and cloned
in the HindIII site of the pAAH5 yeast expression vector [26] to obtain
the recombinant plasmid pALtp1. This recombinant plasmid was used
to transform the W303-1A strain in order to obtain the recombinant
strain W303pALtp1. The cDNA expressing the Ltp1 mutant where the
aspartate 123 was replaced by an alanine and the cDNA expressing the
Fpr3 mutant where the tyrosine 184 was replaced by an alanine were
performed on the pALtp1 and on the pyFpr3 plasmids using Quik-












Strain Genotype Source and reference
W303-1A MATa leu2-3,112 ura3-1 trp1-92 his3-11,15 ade2-1 can1-100, GAL SUC mal [20]
W303pAAH5 W303-1A + pAAH5 [19]
W303pALtp1 W303-1A + pALtp1 This study
W303pALtp1D133A W303-1A + pALtp1D133A This study
W303pyFpr3 W303-lA + pyFpr3 [20]
JK93da MATa his4 HMLa leu2-3,112 rme1 trp1 ura3-52 [24]
KDY86.6a Dfpr3::URA3(JK93da) [24]
KDY86.6apAAH5 KDY86.6a + pAAH5 [20]
KDY86.6apyEP351 Dfpr3::URA3(JK93da) + pyEP351 This study
KDY86.6apALtp1 KDY86.6a + pALtp1 This study
KDY86.6apyFpr3 Dfpr3::URA3(JK93da) + pyFpr3 This study
KDY86.6apyFpr3Y184A Dfpr3::URA3(JK93da) + pyFpr3Y184A This study
BY4743 MATa his3-1, leu2, lys2, ura3-52 Dltp1::KANmx M. Tommasino
Table 2
PTPase activity of clear lysates from Ltp1 and Ltp1D133A over-
expressing strain in comparison to the control
Recombinant strains U/mla mg/ml U/mg
W303 + pAAH5 0.36 8.03 0.045
W303 + pALTP1 1.25 8.9 0.14
W303 + pALTP1D133A 0.36 10.7 0.034
a On pNPP as substrate.
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pyFpr3Y184A, respectively, and used for transformation of W303-1A
to obtain the recombinant strains W303pALtp1 and W303pALtp1-
D133A, respectively. The plasmid pyFpr3, used to obtain the over-
expressing Fpr3 strain, is a gift from Thorner and co-workers [25].
Strain KDY86.6a lacking the Fpr3 gene and its isogenic wild-type
strain JK93da were gifts from Heitman and co-workers [24]. The Ltp1
deletion strain BY4743 was a kind gift from M. Tommasino.
Cells were grown at 30 C either in YP medium (1% yeast extract
and 2% peptone (Biolife)) or in synthetic minimal medium (SD) con-
taining 0.67% w/v YNB (Difco) and appropriate quantities of the
‘‘drop-out’’ amino acid–nucleotide mixture (Bio101). Two percentage
w/v glucose was used as carbon sources. Solid media contained 2% w/v
agar.
Expression of recombinant Ltp1 and Ltp1D133A in S. cerevisiae:
immunoprecipitations and Western blot analysis. Expression of the ac-
tive Ltp1 was assayed for its activity on p-nitrophenylphosphate
(pNPP) as previously described [27]. For immunoprecipitation and
Western blot analysis cells were grown to late exponential phase
(A600 = 1). Cells were harvested by centrifugation and washed in water
and finally the pellet was resuspended in RIPA buffer (50 mM Tris–
HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 2 mM EGTA, and
1 mM sodium orthovanadate) with yeast protease inhibitors cocktail
(Sigma). Cells were broken with glass beads in a Fastprep instrument
(Savant) and protein extracts were clarified by centrifugation at
13,000 rpm for 10 min. For the immunoprecipitation 1 mg of total
proteins was incubated with the specified antibodies in RIPA buffer
and the immunocomplexes were collected on protein A–Sepharose
(Amersham–Pharmacia Biotech), separated by gel electrophoresis
(SDS–PAGE), and transferred to a polyvinylidene-difluoride mem-
brane (PVDF) (Immobilon P; Millipore, Bedford, MA).
For Western blot an amount of 20–100 lg of total proteins was
separated by SDS–PAGE and transferred to PVDF membrane. Im-
munoblot analysis was performed using either anti-PY20 antibodies
(Santa Cruz Biotechnology) at a 1:1000 dilution, anti-phosphotyrosine
monoclonal antibodies 4G10 (Upstaste Biotechnology) at a 1:10,000
dilution, rabbit polyclonal anti-Ltp1 antibody at 1:1000 dilution or
rabbit polyclonal anti-Fpr3 antibody at 1:2000 dilution. The anti-Fpr3
antibodies were a gift from Prof. J. Thorner. Antibodies were detected
by using horseradish peroxidase-conjugated goat anti-rabbit or anti-
mouse secondary antibodies. Immunoblots were visualized by using
ECL reagents (Amersham–Pharmacia Biotech).
Isolation of yeast nuclei. To isolate yeast nuclei 500 ml of expo-
nential growing cultures in YPD medium was collected, resuspended in
1 M sorbitol, 50 mM KPO4 (pH 7.8), 0.5 mM PMSF, 10 mM MgCl2,
and 30 mM DTT to a density of 1 · 109 cells/ml, and incubated at
30 C for 30 min. The cells were collected by centrifugation and re-
suspended in 1 M sorbitol, 25 mM KPO4 + 25 mM sodium succinate(pH 5.5), 0.5 mM PMSF, 10 mM MgCl2, and 2 mM DTT to a density
of 5 · 109 cells/ml with 1 mg/ml Zymolyase. The spheroplasts are ho-
mogenized by 40 strokes with a Dounce homogenizer in Mes (pH 6.4),
10 mM MgCl2, 0.5 mM PMSF, and 0.2% Triton X-100 [28]. The ho-
mogenate was centrifuged at 300g for 10 min to remove cell debris,
nuclei, and mitochondria. The supernatant was centrifuged at 10,000g
and the resulted supernatant was referred to as cytoplasmic fraction.
The pellet obtained from the fist centrifugation described was
centrifuged for 35 min at 38,000g in the previously mentioned buffer
containing 50% of Percoll. Nuclei form a predominant band near the
bottom of the gradient.Results and discussion
Previous studies reported that expression of fission
yeast LMW-PTP Stp1 in S. cerevisiae has a strong influ-
ence on the tyrosine phosphorylation state of many dif-
ferent yeast proteins [19]. In order to obtain S. cerevisiae
strains over-expressing the Ltp1 or its dominant nega-
tive Ltp1 mutant, we separately cloned the correspond-
ing genes into the expression vector pAAH5 that allows
constitutive expression. The corresponding recombinant
plasmids, pALtp1, and pALtpD133A, were used to
transform the W303 yeast strain obtaining the corre-
sponding recombinant strains: W303pALtp1 and
W303pALtp1D133A. The expression of the two pro-
teins was assayed for the enzymatic activity using pNPP
as substrate (Table 2) and Western blot analysis using
polyclonal antibodies against Ltp1 (Fig. 1) to evaluate
the expression of the wild-type and the dominant nega-
tive proteins. The recombinant strain over-expressing
Fig. 1. Western blot analysis of Ltp1 and Ltp1 D133A overexpressing
cells. Lysates from wild-type strain W303pAAH5 (1), W303pALtp1
(2), and W303pALtp1D133A (3) were analyzed by immunoblotting
with anti-Ltp1 antibodies. 20 lg of total proteins were applied in each
lane.
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in comparison with the control indicating the over-ex-
pression of the active Ltp1 protein. The two recombi-
nant clones chosen showed high levels of recombinant
protein expression, as reported in Fig. 1 in which two
bands corresponding to the active (lane 2) and the dom-
inant negative protein (lane 3) in the W303pALtp1 and
W303pALtp1D133A strains, respectively, are shown.
The two bands are evident with respect to the Ltp1 basal
level of the empty vector control strain (lane 1).
Previous work from our laboratory indicated that an-
ti-phosphotyrosine antibodies (PY20) are able to reveal
phosphorylation on tyrosine in a S. cerevisiae strain,
showing that many tyrosine-phosphorylated proteins
are detectable in S. cerevisiae. We analyzed the modifica-
tion of tyrosine phosphorylation in S. cerevisiae
proteome in response to the over-expression of the
LMW-PTP Stp1 or its dominant negative mutant. The
tyrosine phosphorylation level of several proteins de-
creases upon active enzyme expression or increases in
the yeast strain expressing the dominant negative protein.Fig. 2. The phosphorylation pattern and adenine treatment. Panel A. The p
(2). Phosphorylated proteins were detected by immunoprecipitation of 1 mg o
effect on phosphorylated proteins. Lysates from W303pAAH5 (1, 2) and W
immunoprecipitated with antiphosphotyrosine antibodies.Recently we reported that blockage of the Ser/Thr kinase
CK2with specific inhibitor synergizes with the expression
of Stp1 in inducing a severe growth defective phenotype
and we presented in vivo evidence that immunophilin
Fpr3 interacts with and is dephosphorylated by Stp1.
We run a cell growth kinetic in the presence of the CK2
inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB). Analy-
ses of growth kinetics have shown that they are slightly
affected by Stp1 expression alone but this effect is dramat-
ically enhanced by concomitant addition of the specific
CK2 inhibitor. This longer lag phase, observed within
8h after TBB treatment, could correlate with a reduced
level of Fpr3 phosphorylation [20].
Influence of Ltp1 on yeast tyrosine phosphorylation
Our first aim was to assay the capability of Ltp1 to
dephosphorylate yeast substrates in vivo. In order to ex-
plore this aspect, the pattern of tyrosine-phosphorylated
proteins has been analyzed in the recombinant S. cerevi-
siae strain W303pALtp1D133A (expressing the domi-
nant negative mutant) in comparison with the control
strain (harbouring the empty vector). To enhance the le-
vel of tyrosine-phosphorylated proteins we performed
this experiment after an immunoprecipitation using an-
ti-phosphotyrosine antibodies. Cell lysates from the
W303pALtp1D133A strains and from the control strain
were separately subjected to immunoprecipitation with
anti-phosphotyrosine antibodies and immunoprecipi-
tates were resolved by SDS–PAGE. Immunoblot using
anti-phosphotyrosine antibodies was than performed.
The results are reported in Fig. 2A where it is evidenthosphorylation pattern of W303pAAH5 (1) and W303pALtp1D133A
f total proteins with anti-phosphotyrosine antibodies. Panel B. Adenine
303pALtp1D133A (3, 4) were treated with 5 mM adenine and then
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bands in W303pALtp1D133A strain (lane 2) is higher
than in the empty vector control strain (lane 1). Expres-
sion of the negative mutant causes a dramatic increase in
tyrosine phosphorylation level of many proteins with re-
spect to the control strain, suggesting that Ltp1 is very
active in dephosphorylating several different substrates.
It should be noticed, in fact, that only when the domi-
nant negative molecule is expressed, many different
protein species are phosphorylated, while with basal
wild-type Ltp1 expression the equilibrium is shifted to-
wards dephosphorylation. On the other hand, it is well
known that adenine activates more than 30-fold, the
yeast LMW-PTP Ltp1. When W303pALtp1D133A
and control strain lysates were incubated with 5 mM ad-
enine, protein phosphorylation is dramatically reduced
in the W303pALtp1D133A expressing strain lysates
(Fig. 2B, lane 4), becoming very similar to that of the
control strain. This observation indicates that adenine
dependent activation of endogenous Ltp1 overcomes
the effect of dominant negative expression. Adenine ad-
ministration to control strain lysate does not show any
effect, confirming that endogenous Ltp1 is very efficient
in protein dephosphorylation. All these findings suggest-
ed that many yeast tyrosine-phosphorylated proteins
can be dephosphorylated by Ltp1.
Ltp1 dephosphorylates Fpr3 in vivo
In a previous work we have shown that Tyr phos-
phorylated Fpr3 is an in vivo substrate of Stp1, theFig. 3. Fpr3 co-immunoprecipitates with anti-phosphotyrosine from
W303pALtp1D133A. The 70 kDa protein in the immunoprecipitate
from W303pALtp1D133A overexpressing cells is the immunophilin
Fpr3. The immunoblot of Fig. 2A was reprobed with anti-Fpr3
antibodies.
Fig. 4. Fpr3 and Ltp1 in vivo interaction. Panel A: total lysates from W303
immunoprecipitated with anti-Ltp1 antibodies and analyzed by immun
W303pALtp1D133A (1), KDY86.6apAAH5 (2), W303pAAH5 (3) were
immunoblotting with anti-Ltp1 antibodies.S. pombe enzyme 50% identical to Ltp1. To determine
whether the activity of Ltp1 affected the tyrosine phos-
phorylation state of Fpr3, the immunoprecipitates with
anti-phosphotyrosine antibodies shown in Fig. 2A were
reprobed with anti-Fpr3 antibodies. The results are
shown in Fig. 3 where, in the strain expressing the
pALtp1D133A dominant negative mutant, a protein
of apparent molecular mass of 70 kDa was recognized
by anti-Fpr3 antibodies (Fig. 3, lane 2). Because Fpr3,
as detected by immunoblotting with anti-Fpr3 antibod-
ies, was evident only in the strain expressing the inactive
dominant negative protein, we suggest that Ltp1 can di-
rectly dephosphorylate Fpr3. The experiment described
above suggested us to check whether Ltp1 and Fpr3 in-
teract in vivo with each other. This hypothesis was test-
ed using two co-immunoprecipitation assays. Wild-type
strain (expressing basal Ltp1 level) was used together
with the dominant negative expressing mutant (in order
to enhance tyrosine phosphorylation level) and with a
strain lacking Ltp1 expression (in order to rule out the
possibility of an aspecific interaction of Fpr3 with other
endogenous proteins) in an immunoprecipitation assay
using anti-Fpr3 antibodies. The immunoprecipitated
proteins were separated on a SDS–PAGE and analyzed
for the presence of Ltp1 using anti-Ltp1 antibodies. The
immunoblot (Fig. 4A) revealed the presence of the Ltp1
protein in the immunoprecipitate of the strain express-
ing the dominant negative mutant Ltp1D133A (lane 1)
and in the empty vector strain (lane 3) in which the en-
dogenous Ltp1 is still present, but not in lane 2 in which
the endogenous Ltp1 gene is deleted. These results indi-
cate that in both the strains the native Ltp1 or its cata-
lytically inactive mutant can capture Fpr3 as associated
protein. To confirm the interaction between Ltp1 and
Fpr3, the lysates from the strain expressing the domi-
nant negative protein (W303pALtp1D133A) and from
the W303pAAH5 strain expressing the wild-type Ltp1
were immunoprecipitated with anti-Ltp1 antibodies
and the precipitates were immunoblotted with anti-
Fpr3 antibodies. The formation of Ltp1–Fpr3 complex
was again observed only in the strains expressing the
dominant negative Ltp1 (Fig. 4B, lane 1) and in the
empty vector wild-type strain (lane 3). As control strain
we performed the same immunoprecipitation assay inpALtp1D133A (1), BY4743DLTP1pAAH5 (2), W303pAAH5 (3) were
oblotting with anti-Fpr3 antibodies. Panel B: total lysates from
immunoprecipitated with anti-Fpr3 antibodies and analyzed by
Fig. 6. Tyrosine 184 is the major phosphorylation site in vivo. Lysates
from KDY86.6apyFpr3 (1) and KDY86.6apyFpr3Y184A (2) were
immunoprecipitated with anti-phosphotyrosine antibodies and immu-
noblotted with anti-Fpr3 antibodies.
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Therefore, we can conclude that Fpr3 in vivo interacts
with Ltp1. To determine whether the activity of endog-
enous Ltp1 affects the tyrosine phosphorylation state of
Fpr3 and to confirm that Ltp1 is active on Fpr3 in vivo,
we compared the tyrosine phosphorylation level of yeast
Fpr3 in strain not expressing Ltp1 (BY4743DLTP1),
and in the control strain. Lysates from BY4743LTP1
and from the control strain BY4743 were immuno-
precipitated using anti-phosphotyrosine antibodies and
immunocomplexes were probed with anti-Fpr3 antibod-
ies in a Western blot analysis. The results, showed in
Fig. 5, demonstrate that the tyrosine phosphorylation
level of Fpr3 is higher in BY4743DLTP1 strain (Fig. 5,
lane 2), in comparison to the wild-type (Fig. 5, lane 1).
These data confirm that Tyr phosphorylated Fpr3 is
an in vivo substrate of Ltp1.
Tyr 184 is the tyrosine phosphorylation site in Fpr3 in vivo
Pinna and co-workers [29] with in vitro experiments
identified Tyr 184 as the tyrosyl residue phosphorylated
in Fpr3, residing in a highly acidic sequence recognized
by CK2. This pleiotropic enzyme was shown to be re-
sponsible for Tyr phosphorylation of Fpr3 and to be
able to phosphorylate in vitro a tyrosyl peptide repro-
ducing the sequence around Tyr 184. In order to confirm
that this phosphorylation occurs also in vivo, Tyr 184
was changed to Ala by site-directed mutagenesis on
the plasmid YEP351 harbouring the wild-type Fpr3.
The recombinant plasmid yEP351Fpr3Y184A was used
to transform the KDY86.6a [Dfpr3::URA3(JK93da)]
strain which contains disruption in fpr3. This strain
was called KDY86.6apyFpr3Y184A. The expression of
the protein was verified by Western blot analysis using
polyclonal antibodies against Fpr3 (data not shown).
The experiment was performed by immunoprecipitation
with anti-phosphotyrosine antibodies on lysates from
the KDY86.6a transformed either with the plasmid ex-
pressing the wild-type or the mutant Fpr3. The immuno-
precipitates were recognized with anti-Fpr3 antibodies
showing a sharp band only in the strain expressing the
wild-type Fpr3 [KDY86.6apyFpr3] (Fig. 6, lane 1),
confirming that Tyr 184 is the main target of phosphor-Fig. 5. Deletion of ltp1 gene enhances Fpr3 phosphorylation. 1 mg of
lysates from wild-type strain and BY4743DLTP1 strain were immu-
noprecipitated with anti-phosphotyrosine antibodies and immunob-
lotted with anti-Fpr3 antibodies.ylation in Fpr3. In order to verify if this residue is al-
so important for Ltp1–Fpr3 association, lysates
from the same yeast strains [KDY86.6apyFpr3Y184A,
KDY86.6apyFpr3, and from the KDY86.6apyEP351
as control strain] were immunoprecipitated with anti-
Ltp1 antibodies. Immunocomplexes were separated by
SDS–PAGE and immunoblotted using anti-Fpr3 anti-
bodies (Fig. 7A). Fpr3 protein is clearly visible only in
lysates of the strain expressing wild-type Fpr3 (lane 2),
while it is drastically reduced were the dominant nega-
tive is expressed and, as expected, totally absent in
fpr3 null mutant. In panel B the same immunoprecipi-
tates where subjected to anti-Ltp1 immunoblot for nor-
malization. These results demonstrate that Tyr 184 not
only is the main site of phosphorylation of Fpr3, but
is also responsible for Ltp1 binding.
Localization of Fpr3 is independent from its phosphory-
lation on Tyr 184 residue
The subcellular compartment in which Fpr3 resides is
still debated. To determine if tyrosine phosphorylation
and dephosphorylation of Fpr3 might play a role in reg-
ulating its subcellular localization, we examined the
localization of Fpr3 in the fpr3 null mutant strain ex-
pressing either the wild-type Fpr3 (KDY86.6apyFpr3
strain) or the mutant protein Fpr3Y184A (KDY86.6apy-
Fpr3Y184A strain). Lysates from these strains were sub-
cellular fractionated as described in Materials and
methods in order to purify the nuclei from the cytoplas-
mic fraction. The nuclear and cytoplasmatic fractionsFig. 7. The mutant Fpr3Y184A weakly interacts with Ltp1. 500 lg of
total lysate from KDY86.6apyEP351 (1), KDY86.6apyFpr3 (2), and
KDY86.6apyFpr3Y184A (3) were immunoprecipitated with anti-Ltp1
antibodies. The immunoprecipitates were subjected to western blot
analysis using anti-Fpr3 antibodies (A) and anti-Ltp1 antibodies (B).
Fig. 8. Fpr3 cellular localization. 5 lg of nuclear fraction from KDY86.6apyFpr3 (1), KDY86.6apyFpr3Y184A (2) and 50 lg of cytoplasmic
fraction from KDY86.6apyFpr3 (3), KDY86.6apyFpr3Y184A (4) were immunoblotted with anti-Fpr3 antibodies. Lane 5, 20 lg total lysates from
KDY86.6ayEP351.
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blot using anti-Fpr3 antibodies. A signal is predominant-
ly detected in the nucleus in both the strains even when
the mutant protein, in which the Tyr 184 is mutated to
Ala, is over-expressed (Fig. 8). On the basis of these ob-
servations we propose that regulation of Fpr3 localiza-
tion is independent from Tyr 184 phosphorylation.
This is consistent with the fact that Fpr3 is a nuclear pro-
tein and that its tyrosine phosphorylation or dephospho-
rylation does not regulate its subcellular localization.
In conclusion, with this paper we demonstrate that
Ltp1 is very active in dephosphorylating several different
substrates in S. cerevisiae. In particular, we have shown
that Fpr3 clearly interacts and is dephosphorylated in
vivo by Ltp1. Using an appropriate mutant it was also
possible to show that Tyr 184 is the main Fpr3 site of
phosphorylation and is also responsible for Ltp1 bind-
ing and Ltp1 dependent dephosphorylation.Acknowledgments
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